Literature DB >> 23940089

ABT-737 accelerates butyrate-induced death of HL-60 cells. Involvement of mitochondrial apoptosis pathway.

Andrea Stefaniková1, Katarína Kliková, Jozef Hatok, Peter Račay.   

Abstract

The aim of presented study was to determine effect of NaBu in combination with ABT-737 on cell survival of leukemic cell line HL-60. In addition, analysis of molecular mechanism of NaBu action with a focus on mitochondrial apoptosis was performed. Both NaBu and ABT-737 are inducing death of HL-60 cells with different kinetics. ABT-737-induced cell death is fast while NaBu-induced death preceded by cell cycle arrest in G2 phase is rather slow. Cell viability preceded by cell cycle arrest in G2 phase was significantly decreased after 48 hours of incubation with 2 and 5 mmol/l of NaBu while it was significantly decreased after 24 hours of incubation with 1 μmol/l of ABT-737 combined with 2 and 5 mmol/l of NaBu. Incubation of HL-60 cells with NaBu was associated with increased level of pro-apoptotic protein BIMEL and decreased levels of anti-apoptotic proteins of Bcl-2 family as well as GRP78 involved in ER stress signalling. It seems that ABT-737 accelerates NaBu-induced death of HL-60 cells due to mitochondrial apoptosis resulting from ABT-737-mediated inhibition of functions and NaBu-induced decrease of the levels of anti-apoptotic Bcl-2 family proteins as well as due to accelerated decrease of GRP78 observed after the treatment of cells with combination of NaBu and ABT-737. The effect of combination of both drugs on survival of HL-60 cells seems to be synergistic at high concentrations of NaBu (2 and 5 mmol/) while it is rather antagonistic at concentrations of NaBu less than 1 mmol/l. Finally, it might be assumed that NaBu is capable to induce cell death with mechanisms independent from mitochondrial apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23940089     DOI: 10.4149/gpb_2013053

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  3 in total

1.  Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.

Authors:  Jing Ren; Gang Li; Wen Zhao; Ling Lin; Tao Ye
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 2.  Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways.

Authors:  Jiezhong Chen; Kong-Nan Zhao; Luis Vitetta
Journal:  Nutrients       Date:  2019-05-07       Impact factor: 5.717

3.  Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism.

Authors:  Shannon Rose; Sirish C Bennuri; Jakeira E Davis; Rebecca Wynne; John C Slattery; Marie Tippett; Leanna Delhey; Stephan Melnyk; Stephen G Kahler; Derrick F MacFabe; Richard E Frye
Journal:  Transl Psychiatry       Date:  2018-02-02       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.